1st-line therapies in hodgkin lymphoma
Published 3 years ago • 118 plays • Length 3:29Download video MP4
Download video MP3
Similar videos
-
1:17
the importance of risk-adapted therapies in hodgkin lymphoma
-
1:54
therapeutic approaches in the front-line for patients with ptcl
-
0:34
first-line axicabtagene ciloleucel in lymphoma
-
1:37
the role of ctdna in hodgkin lymphoma
-
1:55
exploring first-line car-t therapy for the treatment of dlbcl
-
2:25
warning signs of lymphoma
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
21:13
breakthrough cll treatments: the latest advances in chronic lymphocytic leukemia | the patient story
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
4:03
subcutaneous mosunetuzumab as first-line therapy in high tumor-burden follicular lymphoma
-
2:32
the growing role of anti-pd1 inhibitors in the frontline treatment of hl
-
1:14
pd-l1 inhibitors in r/r hodgkin lymphoma
-
2:03
novel therapeutic agents in the treatment of hodgkin and non-hodgkin lymphoma
-
2:27
using hodgkin lymphoma as a model for immuno-oncologic therapeutic approaches in other lymphomas
-
2:11
allohsct in hodgkin lymphoma post pd-1 inhibitors
-
1:56
optimal therapy sequencing for hodgkin lymphoma
-
2:00
the use of chemotherapy in r/r hodgkin and non-hodgkin lymphomas
-
2:42
the current role of chemotherapy in the treatment of hodgkin lymphoma & the impact of novel agents
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
4:07
hd17: pet guided omission of radiotherapy in hodgkin lymphoma
-
1:59
hodgkin lymphoma: prognostic markers in the era of novel treatments
-
2:00
the incorporation of immunotherapy into frontline all treatment